Asia – Page 24 – pharmaceutical daily

November 30, 2015 Off

Teva and Takeda are forming a new joint venture to operate generics in Japan

Teva and Takeda are forming a new joint venture to operate in Japan

November 30, 2015 Off

India progresses towards polio-free world

“Ours will be the last generation to see the horror of children paralyzed or killed by polio. I am sure,” said Pr Jacob John, Former Christian Medical College, Vellore, Tamil Nadu, India.

“Maybe we will remember 2015 as the year we took the final step to eradicate this disease forever.”

November 27, 2015 Off

(Edited) RPG Life Science calms down investors. Says media writings are premature

By Dino Mustafić

RPG Life Science Limited has said that the media reports which said that “RPG Life Plans Skincare Foray, May Roll Out Biz Next Month” came out premature.

November 26, 2015 Off

GSK in China – escaping the shadow of a scandal

By Dino Mustafić

GlaxoSmithKline Plc has cut 40 percent of its sales reps in China and axed some units as it eyes a return to growth in 2016, after sales plunged during a bribery scandal that landed it with a record $490 million fine in 2014.

November 26, 2015 Off

FDA may withhold approval of Dr. Reddy’s new applications or supplements listing

By Dino Mustafić

The FDA said that, until Dr. Reddy’s complete all corrections and FDA confirms its compliance with CGMP, it may withhold approval of any new applications or supplements listing Dr. Reddy as a drug product or API manufacturer.

November 26, 2015 Off

Teva to receive global development and commercial rights to Hemtares’ novel CGRP antagonists

By Dino Mustafić

Teva will receive exclusive global rights to develop, manufacture and commercialize novel, small-molecule calcitonin gene-related peptide (CGRP) antagonists discovered by Sosei Group’s subsidiary Heptares, for the treatment of migraine.

November 24, 2015 Off

Lupin gets a go-ahead to market Blisovi – generic version Warner Chilcott’s Loestrin tablets – in U.S.

By Dino Mustafić

US FDA has given Lupin a go to market Blisovi Fe 1/20 Tablets and Blisovi 1.5/30 Tablets market generic versions of Warner Chilcott’s Loestrin Fe 1/20 Tablets and Loestrin Fe 1.5/30 Tablets.